Real-time enrollment status for this preclinical alzheimer's disease clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:31 PM UTC
| NCT Number | NCT06957418 |
| Recruiting Status | Recruiting |
| Condition | Preclinical Alzheimer's Disease |
| Phase | PHASE2 |
| Target Enrollment | 900 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Paul S. Aisen |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 16, 2026: Clinical trial NCT06957418 is currently recruiting participants. This phase2 study for preclinical alzheimer's disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Paul S. Aisen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06957418 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06957418 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.